The effect of glibenclamide on insulin secretion at normal glucose concentrations

The effect of glibenclamide on insulin secretion at normal glucose concentrations

Pokaż inne wersje (1)

Aims/hypothesis: The aim of this study was to investigate the incremental and proportional effect of a sulfonylurea on insulin secretion rates at low, elevated and high blood glucose, using parallel groups with ascending or descending glucose steps to minimise potential biases of a single stepped cl...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Riefflin, A, Ayyagari, U, Manley, SE, Holman, R, Levy, J
Format:	Journal article
Język:	English
Wydane:	Springer Verlag 2014

Podobne zapisy

The effect of glibenclamide on insulin secretion at normal glucose concentrations.
od: Riefflin, A, i wsp.
Wydane: (2015)

Glibenclamide-Induced Autophagy Inhibits Its Insulin Secretion-Improving Function in β Cells
od: Jiali Zhou, i wsp.
Wydane: (2019-01-01)

Metformin Ameliorates Dysfunctional Traits of Glibenclamide- and Glucose-Induced Insulin Secretion by Suppression of Imposed Overactivity of the Islet Nitric Oxide Synthase-NO System.
od: Ingmar Lundquist, i wsp.
Wydane: (2016-01-01)

Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
od: Rachman, J, i wsp.
Wydane: (1996)

Aging Affects Insulin Resistance, Insulin Secretion, and Glucose Effectiveness in Subjects with Normal Blood Glucose and Body Weight
od: Li-Ying Huang, i wsp.
Wydane: (2023-06-01)

LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol.
od: Mark K Nøhr, i wsp.
Wydane: (2016-01-01)

Regional Variations of Insulin Secretion and Insulin Sensitivity in Japanese Participants With Normal Glucose Tolerance
od: Kiriko Watanabe, i wsp.
Wydane: (2021-03-01)

The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes
od: Mohanlal, N, i wsp.
Wydane: (2002)

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
od: Holman, R, i wsp.
Wydane: (1979)

HORMONE SIGNALING - BASAL INSULIN-SECRETION AND ACUTE INSULIN-RESPONSE IN NORMAL AND GLUCOSE INTOLERANT MAN
od: Rice, H, i wsp.
Wydane: (1993)

Comparison of different therapies for neonatal diabetes – glibenclamide vs insulin
od: Iberl, M
Wydane: (2012)

Addition of exenatide to insulin therapy in individuals with type 2 diabetes in UK routine clinical practice
od: Price, H, i wsp.
Wydane: (2012)

Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.
od: Fuhlendorff, J, i wsp.
Wydane: (1998)

Comparison of glibenclamide and insulin on neonatal outcomes in pregnant women with gestational diabetes
od: Mitra Behrashi, i wsp.
Wydane: (2016-01-01)

Randomized controlled pilot trial of a hand-held patient-oriented, insulin regimen optimizer
od: Holman, R, i wsp.
Wydane: (1996)

Randomized controlled pilot trial of a hand-held patient-oriented, insulin regimen optimizer.
od: Holman, R, i wsp.
Wydane: (1996)

CO2 utilization as a gas antisolvent in the production of glibenclamide nanoparticles, glibenclamide-HPMC, and glibenclamide-PVP composites
od: Seyed Ali Sajadian, i wsp.
Wydane: (2024-06-01)

LACK OF BENEFIT FROM ACUTE ELEVATION OF PLASMA GLIBENCLAMIDE LEVELS BEFORE MEALS
od: Turner, R, i wsp.
Wydane: (1984)

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations.
od: Turner, R, i wsp.
Wydane: (1979)

CYCLICAL VARIATION (HUNTING) OF BASAL PLASMA GLUCOSE AND INSULIN CONCENTRATIONS IN NORMAL AND DIABETIC MAN
od: Matthews, D, i wsp.
Wydane: (1978)

GLUCOSE AND FREE FATTY-ACID TURNOVER AND ASSESSMENT OF INSULIN SENSITIVITY BY A CONSTANT INFUSION OF GLUCOSE TEST
od: Levy, J, i wsp.
Wydane: (1987)

The role of intermittent continuous glucose monitoring in a successful outpatient transition from insulin to glibenclamide in a patient with transient neonatal diabetes
od: Arthur Lyra, i wsp.
Wydane: (2022-06-01)

Neurotrophin Signaling Is Required for Glucose-Induced Insulin Secretion.
od: Houtz, J, i wsp.
Wydane: (2016)

The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates.
od: Rudenski, A, i wsp.
Wydane: (1988)

Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion
od: Yuren Wang, i wsp.
Wydane: (2018-01-01)

Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose
od: Yulin Zhang, i wsp.
Wydane: (2021-09-01)

Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses
od: Caroline M. M. Loos, i wsp.
Wydane: (2022-05-01)

[Insulin secretion in non-insulin-dependent diabetes]
od: Turner, R, i wsp.
Wydane: (1991)

Insulin secretion in non-insulin-dependent diabetes
od: Turner, R, i wsp.
Wydane: (1991)

Patterns of Insulin Secretion During First-Phase Insulin Secretion in Normal Chinese Adults
od: Tao Yuan, i wsp.
Wydane: (2021-11-01)

Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose Homeostasis
od: Jessica A. Alvarez, i wsp.
Wydane: (2010-01-01)

Subcellular Compartmentalization of Glucose Mediated Insulin Secretion
od: Zhongying Wang, i wsp.
Wydane: (2025-01-01)

Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects.
od: Salgin, B, i wsp.
Wydane: (2009)

Interchangeability of glibenclamide-containing drugs
od: G. I. Gorodetskaya, i wsp.
Wydane: (2018-02-01)

Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response.
od: Levy, J, i wsp.
Wydane: (1993)

Assessment of the effects of metformin and glibenclamide on the concentration of selected trace elements in type 2 diabetic patients
od: Jehan A. Mohammad, i wsp.
Wydane: (2021-11-01)

Physiology of insulin secretion: problems of quantity and timing.
od: Matthews, DR, i wsp.
Wydane: (1985)

Inferring Insulin Secretion Rate from Sparse Patient Glucose and Insulin Measures
od: Rammah M. Abohtyra, i wsp.
Wydane: (2022-08-01)

Glibenclamide inhibits NLRP3 inflammasome-mediated IL-1Î² secretion in human trophoblasts
od: Kazuhiro Tamura, i wsp.
Wydane: (2017-10-01)

Fasting glucose concentration has a greater effect than BMI on insulin pulsatility in normal subjects
od: Ahmed, S, i wsp.
Wydane: (1997)